AM2019 PRO06 Clinical Cases in Gastrointestinal Oncology
This session will be a minimum of 2 case based discussions. The first will be on the management of GE junction cancer and it will discuss the classification, the optimal adjuvant treatment of GE junction cancer, impact of more intensive chemotherapy and targeted agents and management of the patient. The next case will discuss evidence based management of locally advanced rectal cancer including preoperative evaluation, different treatment philosophies in neoadjuvant therapy etc. All cases will also include discussion and delineation of relevant target volumes, emerging clinical trials and where appropriate provide information on emerging molecular prognosticators in keeping with the meeting theme providing a focus on a practical understanding of precision medicine. Time permitting a third case on pancreatic cancer will also be discussed.
The meeting is designed to meet the interests of radiation oncologists and residents.
- Apply evidence based approaches to managing upper GI and Rectal Cancer.
- Explain and discuss rationale for outlining radiation target volumes under different clinical scenarios.
The following persons served as faculty for this activity:
Salma Jabbour, MD is employed at Rutgers University and receives compensation/remuneration/funding from Merck and Nestle.
Najeeb Mohideen, MD, ASTRO is employed at Northwest Community Hospital and has nothing to disclose.
Manisha Palta, MD is employed at Duke University and receives compensation/remuneration/funding from Merck and Varian.
Additionally, the Education and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.